PNC Financial Services Group’s Viking Therapeutics VKTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$259K Buy
7,956
+103
+1% +$3.31K ﹤0.01% 2158
2025
Q4
$276K Buy
7,853
+2,167
+38% +$76.8K ﹤0.01% 2059
2025
Q3
$149K Sell
5,686
-701
-11% -$20.9K ﹤0.01% 2505
2025
Q2
$169K Buy
6,387
+2,530
+66% +$66.6K ﹤0.01% 2322
2025
Q1
$93.1K Buy
3,857
+1,078
+39% +$34.1K ﹤0.01% 2705
2024
Q4
$112K Sell
2,779
-3,460
-55% -$197K ﹤0.01% 2613
2024
Q3
$395K Buy
6,239
+1,396
+29% +$81.9K ﹤0.01% 1709
2024
Q2
$257K Buy
4,843
+1,260
+35% +$82.6K ﹤0.01% 1975
2024
Q1
$294K Buy
3,583
+2,578
+257% +$115K ﹤0.01% 1902
2023
Q4
$18.7K Buy
1,005
+5
+0.5% +$65 ﹤0.01% 3468
2023
Q3
$11.1K Sell
1,000
-669
-40% -$9.57K ﹤0.01% 3709
2023
Q2
$27.1K Buy
1,669
+669
+67% +$14K ﹤0.01% 3402
2023
Q1
$16.6K Hold
1,000
﹤0.01% 3580
2022
Q4
$9.4K Hold
1,000
﹤0.01% 3797
2022
Q3
$3K Sell
1,000
-1,978
-66% -$6.48K ﹤0.01% 4118
2022
Q2
$9K Buy
2,978
+1,978
+198% +$4.89K ﹤0.01% 3853
2022
Q1
$3K Hold
1,000
﹤0.01% 4132
2021
Q4
$5K Sell
1,000
-1,000
-50% -$5.61K ﹤0.01% 3990
2021
Q3
$13K Hold
2,000
﹤0.01% 3678
2021
Q2
$12K Buy
2,000
+500
+33% +$2.97K ﹤0.01% 3653
2021
Q1
$9K Buy
1,500
+500
+50% +$3.52K ﹤0.01% 3687
2020
Q4
$6K Sell
1,000
-4,500
-82% -$27.3K ﹤0.01% 3690
2020
Q3
$32K Buy
5,500
+4,500
+450% +$31K ﹤0.01% 2994
2020
Q2
$7K Hold
1,000
﹤0.01% 3571
2020
Q1
$5K Sell
1,000
-550
-35% -$3.38K ﹤0.01% 3612
2019
Q4
$12K Hold
1,550
﹤0.01% 3475
2019
Q3
$11K Hold
1,550
﹤0.01% 3534
2019
Q2
$13K Hold
1,550
﹤0.01% 3502
2019
Q1
$15K Buy
1,550
+1,250
+417% +$10.5K ﹤0.01% 3475
2018
Q4
$2K Hold
300
﹤0.01% 3879
2018
Q3
$5K Buy
+300
New +$3.57K ﹤0.01% 3830

Other funds holding VKTX